phenserine has been researched along with phenethylcymserine in 2 studies
| Studies (phenserine) | Trials (phenserine) | Recent Studies (post-2010) (phenserine) | Studies (phenethylcymserine) | Trials (phenethylcymserine) | Recent Studies (post-2010) (phenethylcymserine) |
|---|---|---|---|---|---|
| 88 | 6 | 39 | 7 | 0 | 5 |
| Protein | Taxonomy | phenserine (IC50) | phenethylcymserine (IC50) |
|---|---|---|---|
| Cholinesterase | Homo sapiens (human) | 0.006 | |
| Acetylcholinesterase | Homo sapiens (human) | 0.006 | |
| Cholinesterase | Mus musculus (house mouse) | 0.54 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Wang, S; Wang, Y; Wang, Z; Zhang, H | 1 |
| Garcia, CC; Hognason, K; McArdle, JJ; Potian, JG; Routh, VH; Souayah, N; Sultatos, LG; Thyagarajan, B | 1 |
1 review(s) available for phenserine and phenethylcymserine
| Article | Year |
|---|---|
Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Humans; Ligands | 2022 |
1 other study(ies) available for phenserine and phenethylcymserine
| Article | Year |
|---|---|
Acetylcholinesterase deficiency contributes to neuromuscular junction dysfunction in type 1 diabetic neuropathy.
Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; GPI-Linked Proteins; Hyperglycemia; Male; Mice; Motor Endplate; Muscle Weakness; Neuromuscular Junction Diseases; Physostigmine | 2012 |